Interleukin-6 inhibitors in non-COVID-19 ARDS: analyzing the past to step into the post-COVID-19 era
Author:
Funder
The Prince Charles Hospital Foundation
Publisher
Springer Science and Business Media LLC
Subject
Critical Care and Intensive Care Medicine
Link
https://link.springer.com/content/pdf/10.1186/s13054-023-04394-w.pdf
Reference10 articles.
1. National Health Commission of the People’s Republic of China. COVID-19 diagnosis and treatment guideline in China (7th ed.). March 17, 2020. http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989.shtml.
2. Shankar-Hari M, Vale CL, Godolphin PJ, et al. Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis. JAMA. 2021;326(6):499–518. https://doi.org/10.1001/jama.2021.11330.
3. Petrillo A, Biran N, Sadikot S. Use of anti-interleukin-6 receptor monoclonal antibody in drug-induced acute respiratory distress syndrome. Case Rep Crit Care. 2020. https://doi.org/10.1155/2020/8832986.
4. Ibrahim YF, Moussa RA, Bayoumi AMA, Ahmed A-SF. Tocilizumab attenuates acute lung and kidney injuries and improves survival in a rat model of sepsis via down-regulation of NF-κB/JNK: a possible role of P-glycoprotein. Inflammopharmacology. 2020;28(1):215–30. https://doi.org/10.1007/s10787-019-00628-y.
5. Chen K-L, Lv Z-Y, Yang H-W, et al. Effects of tocilizumab on experimental severe acute pancreatitis and associated acute lung injury. Crit Care Med. 2016;44(8):e664–77. https://doi.org/10.1097/CCM.0000000000001639.
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Identification and characterization of putative enhancer regions that direct Il6 transcription in murine macrophages;International Immunology;2024-04-22
2. IL-6 Levels in Acute Respiratory Failure Secondary to Non-COVID-19 Viral Infection;CHEST Pulmonary;2024-03
3. Prone Positioning and Molecular Biomarkers in COVID and Non-COVID ARDS: A Narrative Review;Journal of Clinical Medicine;2024-01-05
4. Muscle-to-organ cross-talk mediated by interleukin 6 during exercise: a review;Sport Sciences for Health;2023-08-01
5. Administration of tocilizumab in septic patients with pancytopenia and hyper-inflammatory syndrome;Annals of Hematology;2023-06-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3